SARS-CoV-2 protein may accelerate fibrosis, inflammation in SSc: Study
SARS-CoV-2, the virus that causes COVID-19, may accelerate the development and progression of systemic sclerosis (SSc) through fibrosis (scarring), inflammation, autoantibody production, and blood vessel damage. That’s according to a study in South Korea that shows the SARS-CoV-2 spike protein that’s required for the…